Agilux Laboratories Announces Validation and Implementation of Thermo Watson Laboratory Information System
WORCESTER, Mass.–()–Agilux Laboratories, a provider of pharmaceutical and biotech services, today announced that it has completed the validation and implementation of the Thermo Watson Laboratory Information Management System (LIMS) for the company’s bioanalytical services.
The Thermo Watson LIMS is the industry Gold Standard for managing bioanalytical data. It is a highly specialized protocol-driven Laboratory Information Management System specifically designed to support DMPK/Bioanalytical studies in drug development.
Growth at Agilux has been fueled by the recognition of its expert bioanalytical capability. With an experienced team of bioanalytical scientists, the latest LC-MS/MS instrumentation, and a commitment to customer service, Agilux Laboratories has the proven track record to solve even the most complex of bioanalytical challenges. Watson enhances this capability and provides a standardized bioanalytical workflow that allows for efficient and compliant sample handling, data processing, and reporting. “It also allows for customization so we can efficiently meet our client’s needs. We want to be able to provide accurate, compliant data in a client specified format as fast as possible,” said Brian Lilley Sr. Director of GLP Bioanalysis.
“Information technology is a key component in our commitment to lead the industry by producing “Better Data Faster” said Jim Jersey, President and CEO at Agilux, “Watson is a central component of that IT infrastructure.”
About Agilux Laboratories:
Agilux Laboratories Inc. is a contract research organization (CRO) that offers “Better Data Faster” across a range of services supporting discovery, pre-clinical and clinical services. Drug Metabolism and Pharmacokinetic (DMPK) services include Fast Turnaround LC-MS/MS bioanalysis, In-Vivo PK and In-Vitro Assays. GLP LC-MS/MS bioanalytical services support pre-clinical and clinical studies.
